Novacap completes th
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
June 28, 2018 12:01 ET | PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
Novacap to expand it
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
June 20, 2018 12:03 ET | PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Celebr
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
February 27, 2018 09:15 ET | PCI Synthesis
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
PCI Synthesis Submit
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
January 30, 2018 09:15 ET | PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Co-Sponsors Third Annual Massachusetts CRO/CMO Symposium
April 22, 2014 09:17 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Apr 22, 2014) -  PCI Synthesis, a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis to Pick Up Four 2013 CMO Leadership Awards
March 10, 2014 09:17 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 10, 2014) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
PCI Synthesis Announces 2014 Trends and Predictions
December 09, 2013 11:23 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 9, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Launches Innovative Product Line: Phosphonic Acids, Used in a Wide Variety of Commercial Applications
December 05, 2013 09:46 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 5, 2013) - PCI (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis Wins Four 2013 CMO Leadership Awards
November 04, 2013 09:13 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Nov 4, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
Glenn Killingworth Joins PCI as VP of Business Development
October 07, 2013 09:30 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Oct 7, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients...